SCHEMBL7987464

SCHEMBL7987464

CCc1nc2ncn(Cc3ccc(OC)c(OC)c3)c2c(=O)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.41
CCNE2 O96020 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
TLR7 Q9NYK1 4/20 0.41
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ROCK2 O75116 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPK1 P28482 2/20 0.39
TSHR P16473 1/20 0.39
ROCK1 Q13464 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
PDE2A O00408 2/20 0.39
CSF1R P07333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985241 0.88 HSP90AA1 (0.45) HPGDTLR7ALDH1A1SMN1; SMN2KMT2A
SCHEMBL7984510 0.84 GAA (0.53) HPGDALDH1A1SMN1; SMN2ROCK2KMT2A
SCHEMBL7987470 0.83 ROCK2 (0.41) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL7985648 0.82 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7987432 0.82 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2ATSHR
SCHEMBL7984524 0.81 HPGD (0.52) HPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL7988126 0.81 HPGD (0.49) HPGDCCNE2CDK4CCND1CCNE1
SCHEMBL7975251 0.80 SMN1; SMN2 (0.60) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7984374 0.80 HPGD (0.43) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7974255 0.80 HPGD (0.47) HPGDCCNE2CCNE1CDK2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed